Kendra D. Tutsch

Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

James P. Thomas, Rhoda Arzoomanian, Dona Alberti et al. · Journal of Clinical Oncology · 2003 · 226 citations

A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced Cancer

Lynn Van Ummersen, Kim Binger, Jennifer Volkman et al. · Clinical Cancer Research · 2004 · 157 citations

Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.

Russell F. Jacoby, Carolyn E. Cole, Kendra D. Tutsch et al. · PubMed · 2000 · 152 citations

Tumor Biology, Chemoprevention Strategy, Selective Cox-2 Inhibition +14

Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol

James P. Thomas, Kendra D. Tutsch, James F. Cleary et al. · Cancer Chemotherapy and Pharmacology · 2002 · 122 citations

Therapeutic Drug Monitoring, Pharmacology, Pharmacokinetic Trial +6

Phase I clinical trial of perillyl alcohol administered daily.

Gregory H. Ripple, Michael N. Gould, James A. Stewart et al. · PubMed · 1998 · 116 citations

Substance Use, Chemoprevention Strategy, Pathology +18